- Generic Biologics
- In-SiteTM PEGylation
 
Search:
Technology Platforms
   
  Antibodies
InSight has in-house expertise and wide experience in developing monoclonal
antibodies and antibody-based products.
Our development platforms include:

• computer-aided epitope design;

• state-of-the-art hybridoma technology;

• molecular design of antibody coding genes-expressing cells;

• Biosimilar mAb development

• Integrated process development for large scale mAb production

• mAb characterization and analysis

• ELISA development
   
 
©2003 InSight Biopharmaceuticals Ltd.
 Company Profile
 Mission
 Our People
 Heparanase
 Generic Biologics